WELLS FARGO & COMPANY/MN - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 77 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2019$452,000
+20.5%
135,701
+10.0%
0.00%
Q3 2019$375,000
+21.0%
123,402
-5.2%
0.00%
Q2 2019$310,000
-43.3%
130,202
-10.7%
0.00%
Q1 2019$547,000
+0.9%
145,802
-3.3%
0.00%
Q4 2018$542,000
-28.8%
150,800
+13.5%
0.00%
Q3 2018$761,000
+50.4%
132,900
+31.7%
0.00%
Q2 2018$506,000
+17.1%
100,887
+19.8%
0.00%
Q1 2018$432,000
-26.0%
84,182
-13.3%
0.00%
Q4 2017$584,000
+120.4%
97,101
+103.1%
0.00%
Q3 2017$265,000
+2108.3%
47,801
+1738.5%
0.00%
Q2 2017$12,0000.0%2,6000.0%0.00%
Q1 2017$12,000
+100.0%
2,600
+420.0%
0.00%
Q4 2016$6,000
+20.0%
500
-4.4%
0.00%
Q3 2016$5,000
-94.2%
523
-96.3%
0.00%
Q1 2016$86,000
-67.3%
14,184
-56.3%
0.00%
Q4 2015$263,000
+139.1%
32,430
+116.4%
0.00%
Q3 2015$110,000
+816.7%
14,989
+1224.1%
0.00%
Q2 2015$12,000
-79.3%
1,132
-82.0%
0.00%
Q1 2015$58,0006,2800.00%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q3 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 4,781,708$24,530,000,0003.64%
Opaleye Management Inc. 950,000$4,873,0001.39%
DSC Advisors, L.P. 1,187,604$6,092,0001.28%
DAFNA Capital Management LLC 335,500$1,721,0000.84%
Vivo Capital, LLC 855,000$4,386,0000.62%
Stonepine Capital Management, LLC 129,756$666,0000.36%
Eversept Partners, LP 107,500$551,4750.26%
Tekla Capital Management LLC 930,398$4,773,0000.19%
Perceptive Advisors 1,117,324$5,732,0000.16%
Crestline Management, LP 217,670$1,117,0000.14%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders